https://peptide.global/story/dr-reddys-semaglutide-relaunch-earnings-recoveryPeptide Globalen2026-10-29T06:07:00.000ZGeneric semaglutide relaunch in November tops Indian drugmaker recovery plan as profit falls https://peptide.global/story/richard-norton-peptide-death-tga-reviewPeptide Globalen2026-10-29T05:24:00.000ZRichard Norton peptide death leads Victorian coroner to seek TGA review https://peptide.global/story/mounjaro-korea-approval-heart-pediatricPeptide Globalen2026-10-29T04:49:00.000ZMounjaro Korea approval adds heart risk and pediatric diabetes uses https://peptide.global/story/hanmi-epe-launch-undercuts-mounjaroPeptide Globalen2026-10-29T03:59:00.000ZHanmi Epe launch in Korea undercuts Mounjaro on starting price https://peptide.global/story/mounjaro-cdsco-alert-kwikpen-batchesPeptide Globalen2026-10-29T03:29:00.000ZMounjaro CDSCO alert flags six KwikPen batches across every strength in India